IN2013MU01286A - - Google Patents

Info

Publication number
IN2013MU01286A
IN2013MU01286A IN1286MU2013A IN2013MU01286A IN 2013MU01286 A IN2013MU01286 A IN 2013MU01286A IN 1286MU2013 A IN1286MU2013 A IN 1286MU2013A IN 2013MU01286 A IN2013MU01286 A IN 2013MU01286A
Authority
IN
India
Prior art keywords
composition
neuropathic pain
treating neuropathic
neuropathy
managing
Prior art date
Application number
Other languages
English (en)
Inventor
Bhaskaran Sunil
Vishwaraman Mohan
Original Assignee
Indus Biotech Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indus Biotech Private Ltd filed Critical Indus Biotech Private Ltd
Priority to IN1286MU2013 priority Critical patent/IN2013MU01286A/en
Priority to PCT/IB2014/060379 priority patent/WO2014162276A1/en
Priority to US14/888,538 priority patent/US10046003B2/en
Priority to EP14779738.5A priority patent/EP2981259B1/en
Priority to ES14779738T priority patent/ES2886534T3/es
Publication of IN2013MU01286A publication Critical patent/IN2013MU01286A/en
Priority to US16/023,068 priority patent/US10561678B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1286MU2013 2013-04-02 2014-04-02 IN2013MU01286A (enrdf_load_html_response)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IN1286MU2013 IN2013MU01286A (enrdf_load_html_response) 2013-04-02 2014-04-02
PCT/IB2014/060379 WO2014162276A1 (en) 2013-04-02 2014-04-02 A composition for treating neuropathy, a process and a method of treatment thereof
US14/888,538 US10046003B2 (en) 2013-04-02 2014-04-02 Composition for treating neuropathy, a process and a method of treatment thereof
EP14779738.5A EP2981259B1 (en) 2013-04-02 2014-04-02 A composition for treating neuropathy, a process and a method of treatment thereof
ES14779738T ES2886534T3 (es) 2013-04-02 2014-04-02 Una composición para el tratamiento de la neuropatía, un procedimiento y un método de tratamiento de la misma
US16/023,068 US10561678B2 (en) 2013-04-02 2018-06-29 Composition for treating neuropathy, process and method of treatment thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1286MU2013 IN2013MU01286A (enrdf_load_html_response) 2013-04-02 2014-04-02

Publications (1)

Publication Number Publication Date
IN2013MU01286A true IN2013MU01286A (enrdf_load_html_response) 2015-04-10

Family

ID=51657656

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1286MU2013 IN2013MU01286A (enrdf_load_html_response) 2013-04-02 2014-04-02

Country Status (5)

Country Link
US (2) US10046003B2 (enrdf_load_html_response)
EP (1) EP2981259B1 (enrdf_load_html_response)
ES (1) ES2886534T3 (enrdf_load_html_response)
IN (1) IN2013MU01286A (enrdf_load_html_response)
WO (1) WO2014162276A1 (enrdf_load_html_response)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104524077A (zh) * 2014-12-22 2015-04-22 蒋亚静 一种用于治疗坐骨神经痛的中药胶囊剂及其制备方法
JP6865426B2 (ja) * 2016-05-02 2021-04-28 ヒノキ新薬株式会社 Ｕｖ感受性軽減剤、ｄｎａ修復促進剤、細胞死抑制剤、及び食品組成物
RU2659202C1 (ru) * 2017-08-04 2018-06-28 Федеральное государственное бюджетное учреждение науки "Национальный научный центр морской биологии" Дальневосточного отделения Российской академии наук (ННЦМБ ДВО РАН) Средство снижения нейропатической боли
CN114460312A (zh) * 2020-11-09 2022-05-10 中国人民解放军军事科学院军事医学研究院 生长激素受体作为抑郁症的生物标志物的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3107605A (en) * 1960-09-23 1963-10-22 Colonial Sugar Refining Co Extracting sucrose from sugar cane
US6451355B1 (en) 2000-07-17 2002-09-17 Howard M. Reisner Composition to treat diabetes
ATE390142T1 (de) * 2003-05-14 2008-04-15 Indus Biotech Pvt Ltd Synergistische zusammensetzung zur behandlung von diabetes mellitus
US20050233013A1 (en) 2004-03-02 2005-10-20 Lee Steve S Methods for enhancing the transport of glucose for balancing blood sugar levels
US7553501B2 (en) * 2006-11-16 2009-06-30 Jose Angel Olalde Rangel Immune phyto-neutraceutical composition
US20080199517A1 (en) * 2007-02-19 2008-08-21 Indus Biotech Private Ltd Composition and a process thereof
US20090012014A1 (en) * 2007-07-02 2009-01-08 Indus Biotech Pvt. Ltd Compound, Composition and a Process Thereof

Also Published As

Publication number Publication date
US20180344755A1 (en) 2018-12-06
EP2981259A1 (en) 2016-02-10
US20160082027A1 (en) 2016-03-24
US10561678B2 (en) 2020-02-18
ES2886534T3 (es) 2021-12-20
US10046003B2 (en) 2018-08-14
EP2981259A4 (en) 2016-11-16
EP2981259B1 (en) 2021-06-09
WO2014162276A1 (en) 2014-10-09

Similar Documents

Publication Publication Date Title
MX2015009037A (es) Enjuague nasal con miel.
HK1220980A1 (zh) 用於治療龐貝氏症的方法和組合物
MX2016004678A (es) Composiciones para el tratamiento del cancer.
EP2970872A4 (en) MICROORGANISMS AND METHOD FOR THE PRODUCTION OF SIALYLATED AND N-ACETYLGLUCOSAMINE-HOLDING OLIGOSACCHARIDES
PH12015501703A1 (en) Trifluormethyl-substituted ring-fused pyrimidines and use thereof
SG10201507607RA (en) Process For Producing Traditional Chinese Medicine Compositions, And Compositions Obtainable By The Process
MX2014007169A (es) Tratamiento de trastorno autoinmune al usar agonistas de rxr.
SG10201703679RA (en) Softening compositions including fermented fruit solutions and methods for making and using the same
MX2016004741A (es) Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico.
EP3226972A4 (en) Methods and compositions for treating migraine and conditions associated with pain
IL246202A0 (en) Methods for t-cell epitope sorting, preparation of t-cell preparations and treatment of diseases
MX377593B (es) Composiciones para usar en el tratamiento de cáncer renal.
EP3137082A4 (en) Methods to treat, prevent, and improve skin conditions
MX2016006688A (es) Inhibidores tetraciclicos de autotaxina.
IN2014DN03464A (enrdf_load_html_response)
ZA201603345B (en) Plant and process for obtaining clear must from grapes and for vinification
IN2013MU01286A (enrdf_load_html_response)
MX2022014763A (es) Composiciones de grapiprant y metodos para usar las mismas.
ZA201604002B (en) Manure treatment process with anaerobic digester
MX2015016603A (es) Composiciones de corticosteroides.
EP3017817A4 (en) Rocuronium preparation with improved vascular pain, method for producing same, and method for suppressing and relieving vascular pain using same
ZA201602073B (en) Compositions and methods for improving plant growth
TN2017000174A1 (en) Low dosage a2a antagonist for the treatment of adhd and parkinsons
LT3157918T (lt) 2-aril-4-hidroksi-1,3-tiazolo dariniai, tinkami naudoti kaip trpm8-inhibitoriai neuralgijos, skausmo, lėtinės obstrukcinės plaučių ligos (lopl) ar astmos gydymui
PT3036321T (pt) Processo de produção de células tronco multipotentes e progenitores, células tronco e/ou progenitores, fragmentos de tecidos de nnct e concentrado de células tronco